GO:0005003 ephrin receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005003 (ephrin receptor activity) is a molecular function defined as combining with an ephrin receptor ligand to initiate a change in cell activity.
• Ephrin receptors (EphA and EphB families) are receptor tyrosine kinases that control cell connectivity, differentiation, and migration.
• Ephrin receptor signaling is critical in enteric neuron connectivity, female reproductive physiology, and epithelial tissue function.
• Dysregulated ephrin receptor activity is implicated in breast cancer, gut and skin epithelia pathologies, and lymphatic valvulogenesis defects.
• Structural studies reveal that pseudokinase domains of Eph receptors can modulate signaling independently of catalytic activity.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect ephrin receptor function in disease and development.
Description
Ephrin receptor activity (GO:0005003) is a molecular function that mediates cell-cell communication by binding ephrin ligands to trigger intracellular signaling. This activity is essential for diverse developmental and physiological processes, including neuronal connectivity, tissue patterning, and reproductive function. Researchers study ephrin receptors to understand how cells interpret their environment and how misregulation contributes to diseases such as cancer and lymphatic disorders. The Eph receptor family comprises EphA and EphB subclasses, which are receptor tyrosine kinases that interact with ephrin-A and ephrin-B ligands, respectively. Beyond classical kinase signaling, Eph receptors can also signal through non-catalytic mechanisms, as shown by structural insights into their pseudokinase domains. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of ephrin receptor activity, its mechanisms, key genes, and experimental approaches.
ephrin receptor activity At A Glance
| GO ID | GO:0005003 |
|---|---|
| GO term | ephrin receptor activity |
| Ontology | molecular_function |
| Synonym | Eph receptor activity |
| Definition | Combining with an ephrin receptor ligand to initiate a change in cell activity. |
| Major function | Cell-cell communication, neuronal connectivity, tissue patterning |
| Related genes | EPHB2, EPHA7, EPHB4, RASA1, PIEZO1 |
| Disease relevance | Breast cancer, gut and skin epithelia, lymphatic valvulogenesis |
What Is GO:0005003?
Ephrin receptor activity (GO:0005003) is defined as the molecular function of combining with an ephrin receptor ligand to initiate a change in cell activity. This activity is synonymous with Eph receptor activity and is a type of transmembrane receptor protein tyrosine kinase activity that enables cells to respond to ephrin signals.
Why Is ephrin receptor activity Important in Cell Biology?
Ephrin receptor activity is fundamental to how cells communicate during development and tissue homeostasis, and its dysregulation is linked to a wide range of pathologies including cancer, reproductive disorders, and lymphatic malformations. Understanding this activity at the molecular level is crucial for developing targeted therapies and for interpreting genomic data in disease contexts.
• Regulates enteric neuron connectivity and activity, impacting gut motility.
• Controls cell differentiation in multiple tissues, including breast, gut, and skin epithelia.
• Plays a key role in female reproductive physiology and pathology.
• Involved in lymphatic valvulogenesis through EPHB4-RASA1-PIEZO1 signaling.
• Dysregulation is associated with breast cancer and epithelial cancers.
• Pseudokinase domains of Eph receptors provide non-catalytic signaling functions.
• Secreted EphA7 promotes somatic cell reprogramming via ERK activity reduction.
• Pan-ephrin receptor kinase inhibitors are being developed as therapeutic agents.
• Ephrin signaling is a model for understanding cell-cell recognition and migration.
• CRISPR-based models enable precise dissection of ephrin receptor gene function.
What Happens During ephrin receptor activity?
Ligand Binding and Receptor Activation
In simple terms: Ephrin receptors on one cell bind to ephrin ligands on another cell, like a key fitting a lock, to start a signal.
Ephrin receptor activity begins when the extracellular domain of an Eph receptor binds to an ephrin ligand presented on an adjacent cell, leading to receptor clustering and activation. This binding initiates a change in cell activity, often through phosphorylation of intracellular tyrosine residues.
Intracellular Signaling Cascades
In simple terms: Once activated, the receptor sends signals inside the cell that can change how the cell behaves.
Activated Eph receptors recruit and phosphorylate downstream effectors, modulating pathways such as ERK and Ras. For example, EPHB4-RASA1 signaling inhibits PIEZO1-mediated Ras activation during lymphatic valvulogenesis. Secreted EphA7 can reduce ERK activity to promote somatic cell reprogramming.
Regulation by Pseudokinase Domains
In simple terms: Some parts of the receptor can control signaling even without being active enzymes themselves.
Structural studies have revealed that pseudokinase domains within Eph receptors can regulate signaling through allosteric mechanisms, independent of catalytic kinase activity. This adds a layer of complexity to ephrin receptor function beyond traditional tyrosine kinase activity.
Cell-Cell Communication and Tissue Patterning
In simple terms: Ephrin receptors help cells talk to each other to organize tissues correctly.
Ephrin receptor activity mediates repulsive and adhesive interactions that guide cell migration and tissue boundary formation. In enteric neurons, EphB2 regulates connectivity and activity, influencing gut function. In female reproductive tissues, ephrin signaling controls follicular development and implantation.
Key Genes Involved in GO:0005003 ephrin receptor activity
The following genes encode proteins that mediate or regulate ephrin receptor activity, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EPHB2 | Regulates enteric neuron connectivity and activity | Studied in gut motility disorders |
| EPHA7 | Secreted form promotes somatic cell reprogramming | Used in stem cell research |
| EPHB4 | Inhibits PIEZO1 Ras activation in lymphatic valvulogenesis | Linked to lymphatic malformations |
| RASA1 | Mediates EPHB4 signaling to PIEZO1 | Involved in vascular development |
| PIEZO1 | Mechanosensitive channel downstream of EPHB4 | Studied in lymphatic valve formation |
| EPHA2 | Regulates cell adhesion and migration | Implicated in breast cancer |
| EPHB3 | Controls cell sorting in gut epithelia | Studied in intestinal homeostasis |
| EPHA4 | Guides axon guidance and neuronal connectivity | Model for neural development |
| EPHB1 | Regulates synaptic plasticity | Studied in neurobiology |
| EPHA1 | Modulates cell proliferation | Investigated in epithelial cancers |
| EPHB6 | Pseudokinase domain regulates signaling | Structural studies |
| EPHA3 | Affects cell survival and differentiation | Studied in reproductive tissues |
| EPHB2 | Influences cell migration | Target for kinase inhibitors |
| EPHA5 | Regulates tissue patterning | Model for developmental biology |
| EPHB4 | Promotes angiogenesis | Target in cancer therapy |
How Is ephrin receptor activity Regulated?
Ephrin receptor activity is regulated at multiple levels, including ligand availability, receptor clustering, and post-translational modifications. Pseudokinase domains can allosterically modulate kinase activity. Additionally, secreted forms of Eph receptors, such as EphA7, can act as decoys or signaling modulators to reduce ERK activity. In lymphatic valvulogenesis, EPHB4-RASA1 signaling inhibits PIEZO1-mediated Ras activation, illustrating cross-talk with mechanotransduction pathways.
ephrin receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EPHB2 | Enteric neuron connectivity disorders | Knockout mouse or iPSC-derived enteric neurons |
| EPHB4 | Lymphatic valvulogenesis defects | Endothelial cell knock-in models |
| EPHA7 | Somatic cell reprogramming efficiency | Overexpression in fibroblasts |
| EPHA2 | Breast cancer progression | Xenograft models with point mutations |
| EPHB6 | Pseudokinase-mediated signaling in cancer | Structural and knockout studies |
Cancer and Epithelial Pathologies
Dysregulated ephrin receptor activity is observed in breast, gut, and skin cancers, where altered Eph signaling promotes cell proliferation, migration, and invasion. Targeting Eph receptors with kinase inhibitors is a promising therapeutic strategy.
Lymphatic and Vascular Disorders
EPHB4-RASA1 signaling defects lead to impaired lymphatic valvulogenesis, contributing to lymphedema and vascular anomalies. This pathway involves PIEZO1-mediated Ras activation, highlighting the interplay between ephrin receptors and mechanosensation.
Reproductive System Disorders
Ephrin and Eph receptor signaling is critical in female reproductive physiology, and its dysregulation is associated with infertility, endometriosis, and reproductive cancers.
Neurological and Enteric Disorders
EphB2 regulates enteric neuron connectivity, and its dysfunction may contribute to gut motility disorders such as Hirschsprung disease. In the nervous system, Eph receptors guide axon guidance and synaptic plasticity, with implications for neurodevelopmental disorders.
From ephrin receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does EPHB2 loss affect enteric neuron connectivity? | CRISPR knockout in mouse enteric neural crest cells |
| Can a point mutation in EPHB4 disrupt RASA1 binding? | Knock-in point mutation in endothelial cells |
| Does secreted EphA7 enhance reprogramming? | Overexpression in somatic cells |
| How does EPHB6 pseudokinase domain regulate signaling? | Tagged knock-in for structural studies |
| Can pan-Eph inhibitors block cancer cell growth? | CRISPR library screening with drug treatment |
| What is the role of EphA2 in breast cancer metastasis? | Knockout and overexpression in breast cancer cell lines |
How to Study the ephrin receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality and pathway dependencies | Identifying modifiers of ephrin signaling |
| Phosphoproteomics | Tyrosine phosphorylation changes | Mapping downstream effectors |
| Live-cell imaging | Receptor dynamics and cell repulsion | Studying cell-cell communication |
| X-ray crystallography | 3D structure of receptor-ligand complexes | Drug design and mechanistic studies |
| RNA-seq | Transcriptional changes upon ephrin stimulation | Identifying target genes |
| Proximity ligation assay | Protein-protein interactions in situ | Detecting EPHB4-RASA1 complexes |
| Flow cytometry | Cell surface expression of Eph receptors | Characterizing receptor levels |
CRISPR Knockout Screening
Genome-wide CRISPR knockout screens can identify genes that modulate ephrin receptor activity and downstream phenotypes, such as cell migration or drug sensitivity.
Phosphoproteomics
Mass spectrometry-based phosphoproteomics measures changes in tyrosine phosphorylation upon ephrin stimulation, revealing downstream signaling networks.
Live-Cell Imaging
Fluorescently tagged Eph receptors and ephrins enable real-time visualization of receptor clustering, internalization, and cell-cell repulsion.
Structural Biology
X-ray crystallography and cryo-EM provide atomic-level insights into Eph receptor ectodomain-ligand interactions and pseudokinase domain conformations.
How CRISPR Can Be Used to Study GO:0005003 ephrin receptor activity
Knockout
CRISPR knockout of Eph receptor genes (e.g., EPHB2, EPHB4) in cell lines or animal models ablates ephrin receptor activity, enabling loss-of-function studies in processes like enteric neuron connectivity and lymphatic development.
Point Mutation
Introducing point mutations in the kinase domain or ligand-binding domain of Eph receptors via CRISPR can dissect catalytic versus non-catalytic functions, such as those mediated by pseudokinase domains.
Knock-in
Knock-in of tagged Eph receptors (e.g., GFP or HA) allows for live-cell imaging and proteomic analysis of receptor complexes under endogenous regulation.
Overexpression
CRISPR activation or cDNA overexpression of Eph receptors or their secreted forms (e.g., EphA7) can enhance signaling and is used to study gain-of-function phenotypes like somatic cell reprogramming.
How EDITGENE Supports ephrin receptor activity Research
Researchers studying ephrin receptor activity-related genes often need to determine whether a candidate gene is causally involved in a specific signaling pathway or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation and functional validation.
Contact EDITGENE today to design your custom CRISPR model for ephrin receptor activity research.
Frequently Asked Questions About ephrin receptor activity
What is ephrin receptor activity?
Ephrin receptor activity (GO:0005003) is the molecular function of binding to an ephrin ligand to initiate a change in cell activity, typically through receptor tyrosine kinase signaling.
What genes are involved in ephrin receptor activity?
Key genes include EPHB2, EPHA7, EPHB4, RASA1, and PIEZO1, among others.
What diseases are associated with ephrin receptor dysfunction?
Dysregulation is linked to breast cancer, lymphatic malformations, reproductive disorders, and enteric neuropathies.
How is ephrin receptor activity regulated?
It is regulated by ligand binding, receptor clustering, pseudokinase domain allostery, and cross-talk with pathways like Ras and ERK.
What research methods are used to study ephrin receptors?
Common methods include CRISPR knockout screens, phosphoproteomics, live-cell imaging, and structural biology.
Can CRISPR be used to study ephrin receptor function?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect ephrin receptor signaling.
What is the role of EPHB4 in lymphatic development?
EPHB4-RASA1 signaling inhibits PIEZO1-mediated Ras activation to drive lymphatic valvulogenesis.
How does EphA7 affect cell reprogramming?
Secreted EphA7 promotes somatic cell reprogramming by inducing ERK activity reduction.
What are pseudokinase domains in Eph receptors?
Pseudokinase domains are structurally similar to kinase domains but lack catalytic activity; they can regulate signaling allosterically.
Why is ephrin receptor activity important in cancer?
Altered ephrin signaling promotes cell proliferation, migration, and invasion in breast, gut, and skin cancers.
Conclusion
Ephrin receptor activity (GO:0005003) is a critical molecular function that governs cell-cell communication in development and disease. Its complexity, including kinase-dependent and independent mechanisms, offers rich opportunities for therapeutic targeting. CRISPR-based models and advanced screening technologies are indispensable for unraveling its roles and translating findings into clinical applications.
References
- 1. Bodin R et al.. 2021. The ephrin receptor EphB2 regulates the connectivity and activity of enteric neurons.. J Biol Chem 297(5):101300 PMID: 34648765
- 2. Madasu C et al.. 2024. Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology.. Proc Natl Acad Sci U S A 121(19):e2322934121 PMID: 38701119
- 3. Sheetz JB et al.. 2020. Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases.. Mol Cell 79(3):390-405.e7 PMID: 32619402
- 4. Lee J et al.. 2015. Secreted Ephrin Receptor A7 Promotes Somatic Cell Reprogramming by Inducing ERK Activity Reduction.. Stem Cell Reports 5(4):480-9 PMID: 26441306
- 5. Chen D et al.. 2024. EPHB4-RASA1 Inhibition of PIEZO1 Ras Activation Drives Lymphatic Valvulogenesis.. Circ Res 135(11):1048-1066 PMID: 39421925
- 6. Adu-Gyamfi EA et al.. 2021. Ephrin and Eph receptor signaling in female reproductive physiology and pathology†.. Biol Reprod 104(1):71-82 PMID: 32940657
- 7. Wilkinson DG. 2014. Regulation of cell differentiation by Eph receptor and ephrin signaling.. Cell Adh Migr 8(4):339-48 PMID: 25482623
- 8. Perez White BE et al.. 2014. Eph receptor and ephrin function in breast, gut, and skin epithelia.. Cell Adh Migr 8(4):327-38 PMID: 25482622
